Dexcom reported $179.8M in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Abbott USD 1.78B 454M Jun/2025
Align Technology USD 124.61M 31.38M Jun/2025
AtriCure USD -6190000 557K Jun/2025
Avanos Medical USD -76800000 83.4M Jun/2025
Baxter International USD 91M 35M Jun/2025
Becton, Dickinson and Co. USD 574M 266M Jun/2025
Boston Scientific USD 797M 123M Jun/2025
Cooper Companies USD 98.3M 10.6M Jul/2025
Dexcom USD 179.8M 74.4M Jun/2025
Edwards Lifesciences USD 333.2M 24.8M Jun/2025
Globus Medical USD 202.85M 127.38M Jun/2025
Hologic USD 194.9M 212.3M Jun/2025
Insulet USD 22.5M 12.9M Jun/2025
Integra LifeSciences USD -484073000 458.78M Jun/2025
J&J USD 5.54B 5.46B Jun/2025
Masimo USD 51.3M 222M Jun/2025
Medtronic USD 1.04B 17M Jul/2025
Merit Medical Systems USD 32.58M 2.43M Jun/2025
Roche Holding CHF 1.01B 2.12B Dec/2024
Solventum Corp 90M 47M Jun/2025
Stryker USD 884M 230M Jun/2025
Tandem Diabetes Care USD -52400000 78.16M Jun/2025
Teleflex USD 122.58M 27.58M Jun/2025
West Pharmaceutical Services USD 131.8M 42M Jun/2025
Zimmer Biomet Holdings USD 152.8M 29.2M Jun/2025